Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2005 September;17(3) > Minerva Biotecnologica 2005 September;17(3):127-31

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

  MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE 

Minerva Biotecnologica 2005 September;17(3):127-31

Copyright © 2006 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of metabolic engineering for the production of secondary metabolites of plants

Khan M. T. H. 1, 2, Ather A. 2, Gambari R. 2, 3

1 Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh; 2 ER-GenTech, Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy; 3 Biotechnology Center, University of Ferrara, Ferrara, Italy


Full text temporaneamente non disponibile on-line. Contattaci


Plants are very interesting and useful sources of molecules of great importance for the development of new pharmaceutical products. Metabolic engineering has proven to be a valuable tool for large production of several biomedically as well as industrially relevant compounds from micro-organisms as well from higher plants. Current development of studies employing transgenic and/or recombinant technologies have opened up opportunities of the metabolic engineering/ metabolo-mics of biosynthetic pathways, leading to the growth of manufacturing of high-value secondary metabolites, even at the commercial level.

inizio pagina